Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
ABSTRACTThe highly mutated BA.2.86, with over 30 spike protein mutations in comparison to Omicron BA.2 and XBB.1.5 variants, has raised concerns about its potential to evade COVID-19 vaccination or prior SARS-CoV-2 infection-elicited immunity. In this study, we employ a live SARS-CoV-2 neutralizatio...
Main Authors: | Yanping Hu, Jing Zou, Chaitanya Kurhade, Xiangxue Deng, Hope C. Chang, Debora K. Kim, Pei-Yong Shi, Ping Ren, Xuping Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2023.2271089 |
Similar Items
-
Detection of SARS-CoV-2 BA.2.86 by lateral flow devices
by: Abbie Bown, et al.
Published: (2024-02-01) -
The SARS-CoV-2 BA.2.86 subvariant: A new challenge in the ongoing pandemic
by: Prakasini Satapathy, et al.
Published: (2024-01-01) -
Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster
by: Julien Favresse, et al.
Published: (2024-06-01) -
Cross-Reactivity Assessment of Vaccine-Derived SARS-CoV-2 T Cell Responses against BA.2.86 and JN.1
by: Muhammad Saqib Sohail, et al.
Published: (2024-03-01) -
JN.1: The new COVID-19 variant of concern?
by: Ruby Dhar, et al.
Published: (2024-02-01)